Pritish Kumar Panda
Pritish Kumar Panda has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Sanjay Jain
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar 470003, M.P., India
8 shared publications - Ankit Jain
Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani
6 shared publications Amit Verma
Department of Pharmaceutics, Amity University, Gwalior, M.P., 474005, India
5 shared publicationsAnkita Tiwari
5 shared publicationsShivani Saraf
Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Central University, Sagar (M.P.), 470 003, India
5 shared publications- Shivani Saraf
Institute of Pharmaceutical Research, GLA University, Mathura, India
3 shared publications
Latest Publications
- 1 March 2026
- Published by Bentham Science Publishers Ltd. in Pharmaceutical Nanotechnology
- Vol. 14 (2) , 230-246
Solid Lipid Nanoparticles and Nanostructured Lipid Particles: A Comparative Review on Lipid-based Nanocarriers
Lipid-based nanocarriers have emerged as promising vehicles for the delivery of various therapeutic agents, owing to their biocompatibility, stability, and ability to encapsulate both hydrophilic and hydrophobic drugs. Among these lipid-based nanocarriers, Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) have gained significant attention in the field of drug delivery. This comparative review aims to provide a comprehensive analysis of SLNs and NLCs, focusing on their formulation, physicochemical properties, drug-loading capacity, stability, and drug release profiles. The review highlights the differences in preparation techniques, particle size, zeta potential, drug encapsulation efficiency, stability, drug delivery, cosmetic and personal care, and food industry applications between SLN and NLC. Furthermore, the review discusses the toxicity and safety profiles of these nanoparticles, including cytotoxicity, genotoxicity, acute toxicity, and long-term toxicity. Finally, the review identifies the potential applications, limitations, and future research directions of SLN and NLC. In summary, this comparative review provides valuable insights into the formulation, physicochemical properties, drug-loading capacity, stability, and drug release profiles of SLNs and NLCs. By understanding the similarities and differences between these lipid-based nanocarriers, researchers and pharmaceutical scientists can make informed decisions regarding the selection of the most suitable nanocarrier for specific therapeutic applications.
- 1 March 2026
- Published by Bentham Science Publishers Ltd. in Pharmaceutical Nanotechnology
- Vol. 14 (2) , 230-246
Solid Lipid Nanoparticles and Nanostructured Lipid Particles: A Comparative Review on Lipid-based Nanocarriers
Lipid-based nanocarriers have emerged as promising vehicles for the delivery of various therapeutic agents, owing to their biocompatibility, stability, and ability to encapsulate both hydrophilic and hydrophobic drugs. Among these lipid-based nanocarriers, Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) have gained significant attention in the field of drug delivery. This comparative review aims to provide a comprehensive analysis of SLNs and NLCs, focusing on their formulation, physicochemical properties, drug-loading capacity, stability, and drug release profiles. The review highlights the differences in preparation techniques, particle size, zeta potential, drug encapsulation efficiency, stability, drug delivery, cosmetic and personal care, and food industry applications between SLN and NLC. Furthermore, the review discusses the toxicity and safety profiles of these nanoparticles, including cytotoxicity, genotoxicity, acute toxicity, and long-term toxicity. Finally, the review identifies the potential applications, limitations, and future research directions of SLN and NLC. In summary, this comparative review provides valuable insights into the formulation, physicochemical properties, drug-loading capacity, stability, and drug release profiles of SLNs and NLCs. By understanding the similarities and differences between these lipid-based nanocarriers, researchers and pharmaceutical scientists can make informed decisions regarding the selection of the most suitable nanocarrier for specific therapeutic applications.
- 1 September 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 114
Lineage of lipid-based endosomal escape in cytosolic delivery to cancer: insight into an unprecedented approach
- 1 September 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 114
Lineage of lipid-based endosomal escape in cytosolic delivery to cancer: insight into an unprecedented approach
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 21 (3) , 313-332
Nanotechnology-based Approaches for Breast Cancer
One common cancer among women is breast cancer. Chemotherapy, radiation therapy, and surgery have historically been used as breast cancer treatments. Thanks to recent technological advancements, we have been able to progressively comprehend the complexity and heterogeneity of diseases, which has led to the development of more effective treatments for many conditions. Working with variably shaped nanoparticles, nanotechnology has recently enabled us to work on tumor targeting and drug delivery, and it has undoubtedly helped to reduce the spread and death of breast cancer. The efficacy of treatment for breast cancer can be increased by a variety of target therapies made possible by nanotechnology. The current review discusses the advantages and disadvantages of nanotechnology-based therapy for breast cancer while also highlighting the disease's current state. The article will provide an overview of the current strategy available for better treatment of breast cancer and aid in understanding the various drug delivery systems designed to provide effective treatment for the disease. By utilizing cutting-edge technologies and early screening, breast cancer fatalities can be decreased. Drug delivery methods based on nano carriers enable medication to reach the target site at the ideal concentration with the least amount of harmful side effects.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 21 (3) , 313-332
Nanotechnology-based Approaches for Breast Cancer
One common cancer among women is breast cancer. Chemotherapy, radiation therapy, and surgery have historically been used as breast cancer treatments. Thanks to recent technological advancements, we have been able to progressively comprehend the complexity and heterogeneity of diseases, which has led to the development of more effective treatments for many conditions. Working with variably shaped nanoparticles, nanotechnology has recently enabled us to work on tumor targeting and drug delivery, and it has undoubtedly helped to reduce the spread and death of breast cancer. The efficacy of treatment for breast cancer can be increased by a variety of target therapies made possible by nanotechnology. The current review discusses the advantages and disadvantages of nanotechnology-based therapy for breast cancer while also highlighting the disease's current state. The article will provide an overview of the current strategy available for better treatment of breast cancer and aid in understanding the various drug delivery systems designed to provide effective treatment for the disease. By utilizing cutting-edge technologies and early screening, breast cancer fatalities can be decreased. Drug delivery methods based on nano carriers enable medication to reach the target site at the ideal concentration with the least amount of harmful side effects.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 25 (14) , 934-952
Role of Vitamins in Therapeutic and Targeting Approaches for Prostate Cancer: An Overview
: Vitamins play a crucial role in cellular functions like cell cycling and proliferation, differentiation, and apoptosis. These also help in the induction of cell cycle arrest and/or apoptosis. They can inhibit normal prostatic epithelial cell growth and might be helpful for the prevention of prostate cancer (PCa). Many essential vitamins including the fat-soluble vitamins (vitamin A, vitamin D, vitamin E, and vitamin K) and the water-soluble vitamins (vitamin B complexes and vitamin C) have a huge impact on the inhibition of growth and progression of PCa. Vitamins show anticancer properties and are involved in regulatory processes like the DNA repairing process, which inhibit the growth of PCa. Consumption of multivitamins prevents methylation of cancer cells and possesses an enormous potential that can be applied for the prevention as well as in the management of PCa. They have a great role in the inhibition of different signalling pathways involved in PCa. Moreover, they have also displayed a significant role in targeting of PCa with various nanocarrier systems. This review encompasses the recent studies about the individual actions of different vitamins and vitamin analogs, the combination of vitamins, and their efficient functions in various therapeutic and targeting approaches for PCa.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 25 (14) , 934-952
Role of Vitamins in Therapeutic and Targeting Approaches for Prostate Cancer: An Overview
: Vitamins play a crucial role in cellular functions like cell cycling and proliferation, differentiation, and apoptosis. These also help in the induction of cell cycle arrest and/or apoptosis. They can inhibit normal prostatic epithelial cell growth and might be helpful for the prevention of prostate cancer (PCa). Many essential vitamins including the fat-soluble vitamins (vitamin A, vitamin D, vitamin E, and vitamin K) and the water-soluble vitamins (vitamin B complexes and vitamin C) have a huge impact on the inhibition of growth and progression of PCa. Vitamins show anticancer properties and are involved in regulatory processes like the DNA repairing process, which inhibit the growth of PCa. Consumption of multivitamins prevents methylation of cancer cells and possesses an enormous potential that can be applied for the prevention as well as in the management of PCa. They have a great role in the inhibition of different signalling pathways involved in PCa. Moreover, they have also displayed a significant role in targeting of PCa with various nanocarrier systems. This review encompasses the recent studies about the individual actions of different vitamins and vitamin analogs, the combination of vitamins, and their efficient functions in various therapeutic and targeting approaches for PCa.
- Open Access
- 15 January 2024
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 14 (1) , 4-8
Preparation and Evaluation of Ketoprofen Loaded Mucoadhesive Microspheres
The aim of the present study was to prepare and evaluate Ketoprofen loaded microspheres fabricated with sodium alginate and Carbopol 934 by ion gelation method which enhances the drug residence time into the stomach by adhering to the mucus layer of and control the rate of drug release for longer period of time. Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used for its analgesic, anti-inflammatory, and antipyretic (fever-reducing) properties. It belongs to the propionic acid class of NSAIDs and is available in various formulations, including oral tablets, capsules, topical gels, creams, and as an injectable solution. In present study ketoprofen incorporates in mucoadhesive drug delivery system for utilizing its controlled drug delivery up to 12 hrs. In present study prepared microspheres were evaluated for- particle size, entrapment efficiency, percentage yield, morphology, mucoadhesive property, in-vitro drug release property. Keywords: Mucoadhesive microspheres, NSAID, ion gelation method, ketoprofen
- 15 January 2024
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 14 (1) , 4-8
Open AccessPreparation and Evaluation of Ketoprofen Loaded Mucoadhesive Microspheres
The aim of the present study was to prepare and evaluate Ketoprofen loaded microspheres fabricated with sodium alginate and Carbopol 934 by ion gelation method which enhances the drug residence time into the stomach by adhering to the mucus layer of and control the rate of drug release for longer period of time. Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used for its analgesic, anti-inflammatory, and antipyretic (fever-reducing) properties. It belongs to the propionic acid class of NSAIDs and is available in various formulations, including oral tablets, capsules, topical gels, creams, and as an injectable solution. In present study ketoprofen incorporates in mucoadhesive drug delivery system for utilizing its controlled drug delivery up to 12 hrs. In present study prepared microspheres were evaluated for- particle size, entrapment efficiency, percentage yield, morphology, mucoadhesive property, in-vitro drug release property. Keywords: Mucoadhesive microspheres, NSAID, ion gelation method, ketoprofen
- 28 February 2022
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 19 (3) , 247-268
Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape
Breast carcinoma (BC) is one of the most frequent causes of cancer-related death among women, which is due to the poor response to conventional therapy. There are several complications associated w...
- 28 February 2022
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 19 (3) , 247-268
Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape
Breast carcinoma (BC) is one of the most frequent causes of cancer-related death among women, which is due to the poor response to conventional therapy. There are several complications associated w...
- 16 October 2019
- Published by Taylor & Francis
- p. 87-114
Application Potential of Pectin in Drug Delivery
Pectin, a naturally occurring, biodegradable heteropolysaccharides, comprised of (1,4)-linked α-d-galacturonic acid entities and numerous neutral sugars like D-galactose, L-arabinose, and D-xylose, etc., has grabbed the attention of scientists in last few years because of its biodegradability, biocompatibility, and non-toxicity. It has found promising applications in an arena of drug delivery and biomedical field. On the basis of its degree of esterification (DE), it has been classified into two major groups, i.e., low methoxy pectin (LMP) and high methoxyl pectin (HMP). The pectin chains combine to form the three-dimensional frameworks leading to the formation of a gel. The pectin properties can be enhanced and chemically altered to form composites, blends for a multiplicity of pharmaceutical applications. It has been utilized potentially as a polymer for targeted drug delivery. This chapter deals with the application potential of pectin in the development of drug delivery systems.
- 16 October 2019
- Published by Taylor & Francis
- p. 87-114
Application Potential of Pectin in Drug Delivery
Pectin, a naturally occurring, biodegradable heteropolysaccharides, comprised of (1,4)-linked α-d-galacturonic acid entities and numerous neutral sugars like D-galactose, L-arabinose, and D-xylose, etc., has grabbed the attention of scientists in last few years because of its biodegradability, biocompatibility, and non-toxicity. It has found promising applications in an arena of drug delivery and biomedical field. On the basis of its degree of esterification (DE), it has been classified into two major groups, i.e., low methoxy pectin (LMP) and high methoxyl pectin (HMP). The pectin chains combine to form the three-dimensional frameworks leading to the formation of a gel. The pectin properties can be enhanced and chemically altered to form composites, blends for a multiplicity of pharmaceutical applications. It has been utilized potentially as a polymer for targeted drug delivery. This chapter deals with the application potential of pectin in the development of drug delivery systems.
- 19 June 2019
- Published by Springer Nature in Pharmaceutical Research
- Vol. 36 (8) , 123
Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis
This investigation was aimed to explore the targeting potential of folate conjugated double liposomes (fDLs) bearing combination of synergistic drugs (Prednisolone and Methotrexate) for effective management of the rheumatoid arthritis (RA).
- 19 June 2019
- Published by Springer Nature in Pharmaceutical Research
- Vol. 36 (8) , 123
Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis
This investigation was aimed to explore the targeting potential of folate conjugated double liposomes (fDLs) bearing combination of synergistic drugs (Prednisolone and Methotrexate) for effective management of the rheumatoid arthritis (RA).
- Open Access
- 21 October 2018
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 24 (39) , 4428-4435
Novel targeting approaches and signaling pathways of colorectal cancer: An insight
Novel targeting approaches and signaling pathways of colorectal cancer: An insight
- 21 October 2018
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 24 (39) , 4428-4435
Open AccessNovel targeting approaches and signaling pathways of colorectal cancer: An insight
Novel targeting approaches and signaling pathways of colorectal cancer: An insight